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Statement of significance 
 
This work reports a new bone substitute made of precipitated apatite crystals that resemble in 
composition and crystallinity to the mineral phase of bone. The bone regeneration capacity of 
this synthetic biomimetic calcium phosphate (SBCP) was studied by using an original model 
of vertical bone regeneration with cups on the calvaria of rats. After 4 weeks, a significantly 
higher bone growth was found for SBCP compared to deproteinized bovine bone matrix 
(DBBM) and empty controls. This rapid vertical bone regeneration together with high 
resorption rate indicated that this new biomaterial is particularly interesting for filling bone 
defects in oral surgery. 
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Abstract 
Bone regeneration is often required to provide adequate oral rehabilitation before dental 
implants. Vertical ridge augmentation is the most challenging of all situations and often 
requires the use of autologous bone grafting. However, autologous bone grafting induces 
morbidity and the harvestable bone is limited in quantity. Alternatives to autologous bone 
grafting include bovine bone derived biomaterials which provide good clinical results and 
synthetic bone substitutes that still fail to provide a reliable clinical outcome. Synthetic 
biomimetic calcium phosphate biomaterials, consisting of precipitated apatite crystals that 
resemble in composition and crystallinity the mineral phase of bone, arise as an alternative to 
both bovine bone and the current sintered bone substitutes. This study aims at comparing the 
vertical bone regeneration capacity of the synthetic biomimetic calcium phosphate (SBCP, 
MimetikOss, Mimetis Biomaterials) with a deproteinized bovine bone matrix (DBBM, Bio-
Oss®, Geistlich Biomaterials) on the calvaria of rats. In order to model vertical bone 
augmentation, hemispherical cups were filled with the two types of biomaterial granules and 
implanted onto the skull of rats while empty cups were used as controls. After 1 day, 4 and 8 
weeks of healing, bone growth was determined by microcomputed tomography and 
histomorphometry. After 4 weeks of implantation, a significantly higher bone growth was 
found in the case of SBCP compared to DBBM and left empty controls. At 8 weeks, no 
statistically significant differences were found between the two bone substitutes. These results 
are promising since vertical bone regeneration was faster in the case of SBCP than for DBBM. 
 
 
Keywords: Vertical bone regeneration, synthetic biomimetic calcium phosphate, 
deproteinized bovine bone Matrix, Hydroxyapatite, cups, calvaria, rats. 
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Introduction 
Bone augmentation is often required prior to the placement of dental implants, especially in 
cases where both vestibular and lingual alveolar bone suffered bone resorption after tooth 
extraction. In this context, one of the major challenges in dental surgery is vertical bone 
augmentation [1,2] which has proven to be highly unpredictable even for experienced surgeons 
[3]. In order to tackle this problem, surgeons use bone grafts that can ensure a predictable and 
reliable clinical outcome. For augmentation of the alveolar bone crest, autologous bone remains 
the gold standard due to its osteogenic properties and similarity with the host tissue. However, 
autologous bone has drawbacks such as morbidity at the donor site, limited quantity and high 
resorption rate [4,5]. The use of bone graft substitutes (BGS) in bone regeneration has proven 
to be efficient in some dental indications, such as sinus lift and alveolar ridge preservation after 
tooth extraction [6,7]. In these particular sites, the BGS is surrounded by several bone walls, 
protecting granulated BGS from potential migration and movements thus favouring bone 
regeneration. However, none of the commercially available dental BGS has demonstrated to 
be reliable in vertical bone augmentation of the alveolar crest [8,9] even if some studies state 
that deproteinized bovine bone matrix (DBBM) is a good candidate for vertical ridge 
augmentation [10]. 
Despite some chemical similarities with the mineral of bone, synthetic calcium phosphate 
bioceramics, such as hydroxyapatite (HA) and beta-tricalcium phosphate (b-TCP), present 
poor bone regenerative properties in large defects and variable resorption rate [11]. The reasons 
may be related to the high sintering temperatures of bioceramics (e.g. 800-1200 °C), which 
confers physicochemical features differing drastically from the mineral phase of bone, which 
is naturally precipitated from body fluids at body temperatures. Xenografts, such as 
deproteinized bovine bone matrix (DBBM) have proven their efficacy in a wide range of dental 
indications but present low bone remodelling capacity over time [12,13]. Furthermore, animal-
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derived products may potentially carry risks of immunological rejection and disease 
transmission such as bovine spongiform encephalopathy [14]. 
Synthetic Biomimetic Calcium Phosphate (SBCP) is a very attractive alternative due to their 
synthesis route. SBCP presents many similarities with natural bone [15]. SBCP, which is 
obtained by precipitation in aqueous media at low temperature, is composed of a calcium-
deficient hydroxyapatite (CDHA) and have low crystallinity resembling the mineral phase of 
bone. These biomimetic materials, e.g. in the form of calcium phosphate cement, have been 
primarily used as bone fillers, although the absence of macro-porosity in cements prevents 
bone ingrowth and limits the regenerative capacity [16,17]. Granules of 0.2-1 mm in size 
present an inter-granular porosity that facilitates body fluid permeability, cell colonization, 
vascularization and bone tissue ingrowth [18]. There is a limited number of studies comparing 
the in vivo performance of DBBM and SBCP granules in a model of vertical bone 
augmentation. In order to mimic the clinical situation of vertical bone augmentation, a 
preclinical model consisting of hemispheric cups filled with biomaterial granules on the 
calvarias of rats is proposed here.  
This study aims at comparing the vertical bone regeneration capacity of a synthetic biomimetic 
calcium phosphate (SBCP, MimetikOss, Mimetis Biomaterials, Spain) and a deproteinized 
bovine bone matrix (DBBM, Bio-Oss®, Geistlich Biomaterials, Switzerland) to promote 
vertical bone formation onto the calvaria of rats. Hemispherical cups were filled with the two 
types of granules and implanted on the skull of rats while empty cups were used as controls. 
After 1 day, 4 and 8 weeks of healing, the biomaterial content and bone growth were 
determined by microcomputed tomography and histomorphometry.   
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Materials and methods 
Hemispherical cups 
Hemispherical hollow cups were drawn by computer-aided design and milled from polymethyl 
methacrylate (PMMA) resin discs (TEMP Basic, Zirkonzahn, Italy). PMMA was chosen 
because of its biocompatibility, radiolucent characteristics and solubility in solvents during 
histological processing. As shown in Figure 1, the cups had an internal diameter of 6 mm and 
fixation reliefs to ensure stability once placed onto the calvaria of rats. 
 
Bone graft substitutes 
Two types of bone graft substitutes (BGS) were used to fill the cups: demineralized bovine 
bone matrix (DBBM, Bio-Oss®, Geistlich Biomaterials, Switzerland) in granular form with 
sizes between 0.25 and 1 mm and synthetic biomimetic calcium phosphate (SBCP, 
MimetikOss, Mimetis Biomaterials, Spain) in granular form with sizes between 0.2 and 1 mm. 
Both BGS were provided in vials sealed into blisters, sterilized by gamma irradiation and used 
following the instructions for use. 
 
Physico-chemical characterization of bone graft substitutes 
The microstructure of the BGS was observed by scanning electron microscopy (Neon 40, Zeiss, 
Germany) operating at 5 kV after metallization with AuV-sputter coating (K950X, Emitech, 
US). Mercury intrusion porosimetry (MIP, AutoPore IV, Micromeritics, USA) was performed 
to determine the pore entrance size distribution. The specific surface area (SSA) was evaluated 
by nitrogen adsorption using the Brunauer–Emmett–Teller theory (Micromeritics, ASAP 2020, 
USA). Samples were also analysed by ATR-FTIR (Nicolet 6700, Thermo Scientific). X-ray 
diffraction (XRD) was performed on the finely ground granules of both DBBM and SBCP. 
Frozen dried sample of bovine bone (obtained from a butcher) was used to compare the 
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composition of BGS to native bone tissue in terms of chemical composition and crystalline 
phases. XRD analyses were performed using a powder diffractometer (D8 Advance, Bruker, 
Germany) with Bragg-Brentano geometry equipped with a germanium monochromator and a 
Cu Kα source operating at 40 kV and 40 mA. Data sets were collected with a step size of 0.019 
° in 2q and a counting time of 1 s per step. The diffraction patterns were compared with files 
from the Joint Committee on Powder Diffraction Standards for α-TCP (JCPDS No. 9-348), β-
TCP (JCPDS No. 9-169) and hydroxyapatite (HA; JCPDS No. 9-432).  Phase quantification 
was performed by comparing the ratios of the area for the most intense peak using the XRD 
analysis software (EVA, Bruker, Germany). 
 
Study Design 
All experimental procedures and protocols were reviewed and approved by the local animal 
care and use ethics committee (Reference of the study CEEA 2012.188 accepted on 
17/01/2013). The European regulation on the use and care of experimental animals was 
followed carefully. Fifty-two Wistar albino rats (strain: Wistar, Rj:Han, adult, male, average 
body weight of 150 g) were purchased from a professional stock breeder (Janvier Labs, Le 
Genest Saint Isle, France). Three animals were placed per cage with pelleted food and water in 
a temperature-controlled room with 12 hours artificial day/night cycle. Animals were 
acclimatised at the Experimental Therapeutic Unit, Faculty of Medicine of Nantes, for a 
minimum of 10 days prior to surgery. The study design consisted of 3 groups: empty cups, 
cups filled with DBBM granules or with SBCP granules; and 3 time points: 1 day, 4 weeks and 
8 weeks (n=6 per group). At 1 day, the empty condition was not considered since the granules 
were not present for histomorphometry analysis. The total number of rats was 48, plus 4 spares, 
giving a total of 52 animals.  
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Surgical procedure 
Each rat was placed on the ventral position under general anaesthesia by inhalation with a mask 
of 3 % isofluorane (Forane®, Baxter Healthcare Corp., USA) in air at a flowrate of 1 L/min. 
The head was shaved and disinfected with 10 % povidone iodine solution (Betadine®, Scrub) 
and sterile gauzes. Local anaesthesia was performed by subcutis injection of adrenaline 
articaine hydrochloride (0.2 ml, Alphacaine SP, Dentsply, France). Pre- and post-operative 
analgesia was provided by intramuscular injection of buprenorphine (30 µl/kg, 2 times/day for 
3 days, Buprécare, Axience, Pantin, France). The animals were identified with numbered ear 
tags. The bone calvaria was exposed by a lateral incision and smooth dissection. The 
periosteum was incised and detached from the bone calvaria. A cup, either left empty or filled 
with the BGS granules, was placed onto the bone calvaria. To ease the filling of the cup, the 
BGS granules were hydrated with physiological saline. The surgical wound was carefully 
closed with non-absorbable polyamide 4/0 sutures (Peters Surgicals, Bobigny, France). After 
1 day, 4, and 8 weeks of implantation, the animals were euthanized by prolonged inhalation of 
carbon dioxide gas. The site was dissected and examined for signs of tissue necrosis, 
inflammation or infection. The calvaria was cut using a circular diamond saw mounted on a 
dental hand piece (NM3000, Nouvag, Switzerland). Immediately after dissection, samples 
were fixed in 10 volumes of neutral 4% formaldehyde (Microm Microtech, France) and stored 
at 4 °C for a minimum of 3 days.  
 
Microcomputed tomography 
Microcomputed tomography (micro-CT) analysis was performed on calvaria after 1 day, 4 
weeks and 8 weeks using a high-resolution X-ray micro-CT system for small-animal imaging 
(micro-CT 1076, SkyScan, Kontich, Belgium). All samples were scanned using the same 
parameters (pixel size 9 µm, 50 kV, 0.5 mm Al filter and 0.8 ° of rotation step). Three-
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dimensional reconstructions were made using a software (CTVOX, Skyscan, Belgium) to 
evaluate the filling capacity of the BGS in the cup. Bone and biomaterial volume over total 
volume (BV+MV)/TV were determined in the cup owing to a software allowing to finely select 
the threshold (CTAN, Skyscan, Belgium) on 3 samples for each time point. 
 
Histology and histomorphometry 
The samples were decalcified with 5 % ethylene diamine tetra acetic acid (EDTA) and 0.2 % 
paraformaldehyde in phosphate-buffered saline (PBS) for 96 h using a microwave automate 
(KOS Microwave, HistoStation, Milestone Medical, USA). The samples were then rinsed with 
tap water and dehydrated in ascending series of 80, 95 and 100 % ethanol baths, and finally in 
butanol for 30 min (Automated dehydration station, Microm Microtech, France). After 
dehydration, the PMMA cup was dissolved in acetone. The samples were then immersed in 
liquid paraffin at 56 °C (Histowax, Histolab Products AB, Sweden) and embedded at -16 °C. 
Blocks were cut by using a standard microtome (RM2250, Leica, Germany). Thin histological 
serial sections (3-5 µm) were performed perpendicular to the calvaria in the middle of the cup. 
The slices were mounted on microscope glass slides (Polysine, Thermo Scientific, Germany) 
and stained with Masson’s trichrome using an automated staining station (Microm Microtech). 
This staining combines haematein for cell nuclei (purple/black), fushin Ponceau for cytoplasm, 
muscle and erythrocytes (red) and light green solution for collagen (green/blue). The stained 
slices were scanned (NanoZoomer 2.0RS, Hamamatsu Corp. Japan) and observed with the 
virtual microscope (NDP view software, Hamamatsu Corp). The parameters quantified in the 
region of interest (Figure 1) by histomorphometric analysis (Image J,	National Institute of 
Health, USA) were the area percentages of biomaterial (MS/TS), bone (BS/TS) and residual 
tissues (RS/TS). The vertical bone regeneration in the cup was determined by calculating the 
percentage of newly formed bone in the free space, defined as follows: 
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% Bone surface in free space = (BS/(BS+RS)) x 100 
where: 
 BS is the bone surface in the region of interest 
 MS is the biomaterial surface in the region of interest 
 TS is the total surface of the region of interest 
 RS is the residual tissue surface of the region of interest 
 
Statistical analysis 
Based on a statistical power calculation, 6 animals were used per group. Data are presented as 
average ± standard deviation. Statistical differences were determined using one-way ANOVA 
with Tukey’s post hoc tests using Minitab 16 software (Minitab, Inc., USA). Statistical 
significance was considered for p value < 0.05. 
 
Results 
Physico-chemical properties of the bone graft substitutes 
The morphology and microstructure of the two bone graft substitutes (BGS) were observed by 
scanning electron microscopy (SEM). As illustrated in Figure 2, the Demineralized Bovine 
Bone Matrix (DBBM) granules showed an irregular shape with one large and two short 
dimensions, while the synthetic biomimetic calcium phosphate (SBCP) granules appeared 
spherical. At high magnification, the DBBM surface exhibited aligned micropores whereas 
needle-like crystals were observed on the SBCP surface. 
The pore size distribution was measured by mercury intrusion porosimetry. Both BGS 
presented a bimodal pore entrance size distribution (Figure 3). The left peak, corresponding to 
the smallest pore entrance diameters, was considered to represent the micro/nano porosity of 
the granules themselves (intra-granule porosity). These peaks were in the range 0.01-0.03 µm 
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and 0.10 µm for DBBM and SBCP, respectively. The right peak, at higher entrance pore sizes, 
corresponded to the spaces between the granules (inter-granular porosity). Peaks had a 
maximum value at 200 µm and 150 µm for DBBM and SBCP, respectively. The peak of inter-
granular macro-porosity exhibited by SBCP was wider than the one of DBBM. Quantification 
of the corresponding pore volumes led to the determination of the intra-granular microporosity 
(<10 µm), inter-granular porosity (> 10 µm) and total porosity, as presented in Table 1. DBBM 
was found to have a slightly higher intra-granular micro-porosity than SBCP, while the inter-
granular porosity of SBCP was substantially higher. SBCP presented a higher total porosity 
than DBBM. The SSA, as measured by Nitrogen adsorption is also reported in Table 1. The 
SSA of DBBM was higher than that of SBCP by an order of magnitude. 
The FTIR spectra of the two biomaterials, together with that of the frozen dehydrated bovine 
bone, are shown in Figure 4a. Both DBBM and SBCP exhibited the phosphate bands of 
hydroxyapatite, similarly to what was found in dehydrated bone. In natural bone, these 
phosphate bands coexist with others assigned to the organic compounds, namely collagen and 
other extracellular matrix proteins. The XRD patterns of the different biomaterials are shown 
in Figure 4b. DBBM consisted of a hydroxyapatite phase with a comparable crystallinity as 
found in natural bone. SBCP was composed of two crystalline phases, calcium deficient HA 
and b-TCP in a weight proportion of 80 % and 20 %, respectively.  
 
Comparison of vertical bone regeneration on the calvaria of rats 
After surgery, all animals exhibited normal clinical symptoms and the sutures were checked 
for correct healing. Rats were all feeding themselves correctly after a few hours as analgesia 
was maintained during the first 72 hours. No major pain symptoms were observed after this 
period and animals gained weight normally. At sacrifice after 4 and 8 weeks, no signs of 
infections or tissue necrosis were noticed. 
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Microcomputed tomography (micro-CT) reconstructions are provided in Figure 5. Newly 
formed bone was not found in the empty cups after 4 and 8 weeks. In general, the granules 
were well packed and maintained into the cups, although some granules were found outside 
one day, 4 and 8 weeks after surgery. As reported in Table 2, the (BV+MV)/TV calculations 
indicated the absence of newly formed bone in the left empty cups after 4 and 8 weeks 
indicating the validity of this vertical bone augmentation model. One day after surgery, the 
cups appeared to be well-filled with granules for both types of biomaterials although the 
quantity was higher for SBCP than for DBBM due to the higher packing of spherical granules. 
The (BV+MV)/TV gradually increased from 1 day to 8 weeks for the DBBM. The 
(BV+MV)/TV of the SBCP first decreased from 1 day to 4 weeks before increasing to a similar 
value as DBBM after 8 weeks. Both groups of biomaterials filled cups had similar 
(BV+MV)/TV values after 8 weeks.  
Decalcified histology was employed to directly observe the tissues formed within the cups 
around biomaterial granules as micro-CT did not allow the distinction between bone and 
biomaterial with similar grey levels. A representative histology section of each condition at 
each time point is reported in Figure 6 at low magnification and at high magnification in 
Figures 7-9 . When the cup was left empty, a very limited vertical bone growth was observed 
at both 4 and 8 weeks after surgery. The calvaria bone exhibited a vertical thickening with a 
newly formed non-woven bone that originated from the periosteum while most of the cup was 
filled with a necrotic tissue at 4 weeks (Figures 6 and 7). Thickening of the cortical bone was 
also observed at 8 weeks with mature lamellar bone covered by a thin vascularized fibrous 
tissue. Numerous necrotic cells occupied the rest of the left empty cups. In the case of DBBM, 
some bone formation was observed at 4 weeks in the “cortical” area originating from the 
periosteum (Figures 6 and 8). Woven bone was observed between the granules and a few blood 
vessels were distinguished. The “cup” area showed limited signs of bone formation at 4 weeks 
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but was filled with newly formed bone at 8 weeks. The majority of DBBM granules were 
encapsulated in a vascularized fibrous tissue without macrophages or giant cells typical of a 
foreign body reaction. For cups filled with the SBCP granules, newly formed bone was 
observed in the cortical area with some fibro-vascular tissue at 4 weeks (Figures 6 and 9). The 
SBCP granules appeared surrounded by a mineralized collagen tissue with osteoblastic cells. 
Bone formation at 8 weeks in this area was complete and the granules were surrounded by 
lamellar bone close to the cortical bone and woven bone in the rest of the cup. Again, 
osteoblastic cells were observed around the SBCP granules with macrophages indicating a 
foreign body reaction. The cup area showed limited signs of bone formation at 4 weeks and 
good bone formation between granules at 8 weeks, as shown in Figure 6 and 9. 
As shown in Figure 10, histomorphometry corroborated that SBCP presented superior bone 
formation capacity in the “cortical” area compared to DBBM or empty conditions at 4 weeks 
(p=0.002).  The density of bone in free space was statistically higher for SBCP as compared to 
DBBM at 4 weeks with a p-value of 0.01. At 8 weeks, no statistically significant differences 
were observed between DBBM and SBCP, showing a percentage of bone between the 
biomaterial granules of 60.6 ± 14.1 % and 73.3 ± 18.8 %, respectively. The values of MS/TS 
(Figure 10) obtained by histomorphometric analysis corroborated that SBCP granules pack 
better into the cup, although no statistically significant differences were observed between the 
two biomaterials (p=0.09). The MS/TS value did not change over time for both types of 
biomaterial. 
 
Discussion 
The use of novel biomimetic synthetic calcium phosphate bone substitute that resembles 
closely the mineral phase of bone is of high interest for bone regeneration. Biomimetic 
materials are the focus of many research teams since they are claimed to possess superior 
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osteoconductive properties owing to their micro/nano porosity and their high specific surface 
area which is lower than DBBM but can still be considered as a high value as compared to 
other synthetic calcium phosphate bioceramics produced mainly by sintering at high 
temperatures [19][20].  
The empty cup was considered as the negative control condition, although some bone growth 
was observed at 4 and 8 weeks, suggesting that the initial stimulation by scratching cortical 
bone sufficed to stimulate a slight bone growth even in the case where no scaffolding was 
provided. This overgrowth of calvaria bone has also been reported in a rabbit model [21]. 
Based on the hypothesis that the two tested biomaterials presented different initial packing 
abilities, the percentage of bone between granules was calculated by using a method described 
by Flautre et al. [22]. SBCP recorded a significantly higher value of bone in the free spaces at 
4 weeks, while the difference was not significant at 8 weeks, as compared to DBBM. This 
result suggests that synthetic biomimetic calcium phosphate granules are able to conduct bone 
ingrowth faster than demineralized bovine bone matrix granules. The shape of the granules, 
their micro structure and the higher total porosity can be partly responsible for the faster bone 
regeneration capacity of SBCP as compared to DBBM [20].  These results suggest that SBCP 
is superior to DBBM and that a possible faster mode of action makes this type of biomimetic 
calcium phosphate biomaterial a good candidate for their use in challenging dental indications 
such as vertical bone augmentation. Further studies are needed in a large animal model in a 
dental indication to further confirm the findings of the present study. Nevertheless, none of the 
condition indicated a complete filling of the cups with bone tissue. It will be of interest to 
conduct a similar experiment with bone marrow derived mesenchymal stem cells associated to 
the biomaterial in order to induce bone tissue formation, as previously reported [23]. Another 
limitation of our study concerns vascularization that is key to bone regeneration. The 
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proportion of blood vessels at 4 and 8 weeks was superior for SBCP than for DBBM but 
remained insufficient for a complete bone regeneration in the cups.  
 
Conclusion 
Synthetic biomimetic calcium phosphate granules were evaluated as a good candidate for 
vertical bone augmentation. This new bone graft substitute outperformed DBBM in terms of 
bone formation rate since newly formed bone tissue was more abundant at 4 weeks of 
implantation for SBCP. Furthermore, owing to their physicochemical characteristics and 
packing features, the SBCP granules have a great potential for alveolar bone ridge 
augmentation. 
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